Pasithea Therapeutics KTTA Cash Flow Statement (2021-2026)

NASDAQ KTTA
$0.47 -0.02 (-4.08%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.73M-1.53M0.63M-0.33M-0.47M0.40M-3.42M-0.27M-0.17M-0.08M-3.86M-3.87M-3.00M-3.18M-3.56M-3.72M-3.04M-10.11M-2.87M
Depreciation and Depletion (Quarter)
0.01M-0.00M-1.000.00M0.00M0.00M0.00M0.00M0.00M0.01M0.00M0.00M0.00M0.00M0.02M-421.00
Share-based Compensation (Quarter)
0.30M0.01M0.44M0.03M0.10M0.02M0.42M0.15M0.19M0.10M-0.00M0.30M0.13M0.12M-0.01M0.10M0.06M0.09M0.09M0.72M
Cash from Discontinued Operations (Quarter)
-0.41M0.01M-0.63M-0.77M-0.18M-0.40M-0.01M-0.02M
Gains from Investment Securities (Quarter)
0.25M-2.59M-0.42M0.34M-0.98M0.05M-0.11M-0.04M0.06M-0.03M0.04M0.07M-0.00M-0.08M0.01M-0.05M
Asset Writedowns and Impairment (Quarter)
960.00960.00960.00
Cash from Operations (Quarter)
-0.50M-0.55M-1.74M-2.15M-1.94M-4.62M-3.19M-3.20M-3.08M-3.24M-3.29M-4.32M-4.04M-3.12M-2.44M-3.06M-3.87M-2.89M-5.40M-4.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.02M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.00M0.00M0.00M0.02M-421.00
Change in Working Capital
Change in Account Payables (Quarter)
-0.02M
Change in Accured Expenses (Quarter)
0.22M0.07M-0.08M0.03M0.03M0.41M0.28M-0.03M0.47M-0.05M0.68M-0.12M-1.04M-0.76M0.48M0.21M0.26M-0.24M-0.21M0.36M
Other Working Capital Changes (Quarter)
-0.05M0.56M-0.00M-963.00
Investing Activities
Capital Expenditures (Quarter)
0.01M0.00M0.01M0.01M0.09M0.05M0.00M-0.02M-36.00
Sales of Property, Plant and Equipment (Quarter)
0.03M0.05M
Acquisitions (Quarter)
0.02M2.25M
Divestments (Quarter)
-0.11M-0.43M-0.16M0.07M0.00M0.32M
Cash from Investing Activities (Quarter)
-0.01M-0.00M0.07M-0.03M-2.34M-0.05M0.02M0.05M0.05M
Financing Activities
Other financing activities (Quarter)
-5.00M871.004.21M-2.93M-0.83M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
20.65M5.30M0.13M0.26M0.18M
Change in Capital Stock
Shares Issued (Quarter)
0.60M0.10M0.10M0.25M0.07M15.36M15.36M1.98M0.10M0.18M0.77M0.19M0.02M0.16M0.15M0.11M1.69M0.13M
Net Equity Issued and Repurchased (Quarter)
4.50M1.65M0.36M2.20M-2.14M
Misc.
Cash from Financing Activities (Quarter)
20.55M34.17M0.26M-0.13M-3.86M-0.02M1.47M5.74M-0.12M56.42M750.00
Exchange Rate Effect (Quarter)
-0.00M-0.01M-0.00M-0.04M-0.08M0.14M-0.00M-317.00-0.00M0.00M-620.00-0.00M-0.03M0.03M0.01M465.000.03M
Change in Cash (Quarter)
-0.50M20.00M32.40M-2.68M-2.33M-5.52M-9.29M-3.17M-3.27M-7.06M-3.25M-4.32M-4.04M1.39M-2.44M-1.58M1.88M-2.99M51.04M-4.76M
Free Cash Flow (Quarter)
-0.50M-0.55M-1.76M-2.15M-1.94M-4.63M-3.28M-3.26M-3.08M-3.22M-3.29M-4.32M-4.04M-3.12M-2.44M-3.06M-3.87M-2.89M-5.40M-4.79M
Net Cash Flow (Quarter)
-0.50M20.01M32.41M-2.15M-1.87M-4.65M-5.53M-2.99M-3.19M-7.05M-3.24M-4.32M-4.04M-3.12M-2.47M-1.58M1.87M-3.01M51.02M-4.79M